Broderick Brian C

SEC CIK: 0001314376
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

NVS holding history

Novartis AG in every 13F filed by Broderick Brian C, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overview All 13F holders of NVS Full Q2 2026 holdings

Shares (Q2 2026): 2,946
Value: $461.7K
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of NVS by Broderick Brian C, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	2,946	$461.7K	0.1%	−175−5.6%	Reduced	Holders
Q1 2026	3,121	$476.7K	0.1%	00.0%	Unchanged	Holders
Q4 2025	3,121	$430.3K	0.1%	00.0%	Unchanged	Holders
Q3 2025	3,121	$400.2K	0.1%	−1,082−25.7%	Reduced	Holders
Q2 2025	4,203	$508.6K	0.1%	−70−1.6%	Reduced	Holders
Q1 2025	4,273	$476.4K	0.1%	−3,800−47.1%	Reduced	Holders
Q4 2024	8,073	$785.6K	0.2%	−3,960−32.9%	Reduced	Holders
Q3 2024	12,033	$1.38M	0.3%	−6,780−36.0%	Reduced	Holders
Q2 2024	18,813	$2.00M	0.4%	−3,021−13.8%	Reduced	Holders
Q1 2024	21,834	$2.11M	0.5%	−6,126−21.9%	Reduced	Holders
Q4 2023	27,960	$2.82M	0.7%	−1,055−3.6%	Reduced	Holders
Q3 2023	29,015	$2.96M	0.8%	+1,425+5.2%	Added	Holders
Q2 2023	27,590	$2.78M	0.7%	−360−1.3%	Reduced	Holders
Q1 2023	27,950	$2.57M	0.7%	−525−1.8%	Reduced	Holders
Q4 2022	28,475	$2.58M	0.8%	−1,930−6.3%	Reduced	Holders
Q3 2022	30,405	$2.31M	0.7%	−1,980−6.1%	Reduced	Holders
Q2 2022	32,385	$2.74M	0.8%	−3,848−10.6%	Reduced	Holders
Q1 2022	36,233	$3.18M	0.8%	−4,867−11.8%	Reduced	Holders
Q4 2021	41,100	$3.60M	0.9%	−27,295−39.9%	Reduced	Holders
Q3 2021	68,395	$5.59M	1.5%	−12,109−15.0%	Reduced	Holders
Q2 2021	80,504	$7.34M	2.0%	−4,869−5.7%	Reduced	Holders
Q1 2021	85,373	$7.30M	2.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.